Loading
A phase 1/2 trial of cyclophosphamide, fludarabine and cetuximab in colorectal cancer, run by M.D. Anderson Cancer Center, now recruiting.
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial") is a phase 1/2, interventional study registered as NCT07411599 by M.D. Anderson Cancer Center, with a registry enrolment figure of 28 participants, started 2026-04-20 and due to reach its primary completion in 2028-11-15. Interventions recorded: Cyclophosphamide; Fludarabine; Cetuximab; NK Cells. Conditions listed: Colorectal Cancer; Peritoneal Metastases; Carcinomatosis. Primary outcome: Safety and adverse events (AEs. Colorectal eligibility wording from the registry: "o History of hysterectomy or bilateral salpingo-oophorectomy". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fludarabine, Cyclophosphamide, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fludarabine, Cyclophosphamide, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.